Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
Connective Tissue Oncology Society (CTOS)
Connective Tissue Oncology Society (CTOS)
The
Connective Tissue Oncology Society
(
CTOS
) was formed in 1995 and incorporated in 1997. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research.
Trabectedin or Gemcitabine-Taxotere in Relapsed Uterine Leiomyosarcoma (U-LMS)
CTOS 2016
Read More ›
Phase 2 Study of Regorafenib in Patients with Metastatic STS (RESOUND)
CTOS 2016
Read More ›
Adjuvant Therapies in Major Histological Subtypes of Extremity Soft-Tissue Sarcoma (STS)
CTOS 2016
Read More ›
Alternate Dosing Regimen of Regorafenib in Gastrointestinal Stromal Tumors (GISTs)
CTOS 2016
Read More ›
Outcomes of Older Patients with Osteosarcoma from the French Group Sarcoma (GSF-GETO)
CTOS 2016
Read More ›
Trabectedin Approved for Use in Uterine Leiomyosarcoma
CTOS 2016
In this interview, Martee Hensley, MD, a medical oncologist practicing at Memorial Sloan Kettering Cancer Center, commented on the introduction of trabectedin as a treatment alternative for women with uterine leiomyosarcoma.
Read More ›
Page 2 of 2
1
2
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us